Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042608

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042608

Biochips Based In-Vitro Diagnostics Market, By Product Type, By Application, By End-User, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

PUBLISHED:
PAGES: 333 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF & Excel (Enterprise User License)
USD 5650

Add to Cart

Biochips Based In-Vitro Diagnostics Market size was valued at US$ 7,360.8 Million in 2025, expanding at a CAGR of 9.1% from 2026 to 2033.

Biochips based in-vitro diagnostics (IVD) are innovative laboratory testing methods that use tiny biological chips to study blood, tissue, saliva, or other body samples outside the human body. These biochips can implement multiple tests at the same time on a very small platform, facilitating healthcare professionals recognize infections, genetic conditions, cancer markers, and metabolic disorders more quickly and precisely. Technologies such as microarrays, biosensors, and lab-on-chip systems are commonly used in these diagnostics.

These diagnostics is slowly increasing as healthcare systems place its importance on early diagnosis, personalized treatment, and rapid testing solutions, maintained by stronger regulatory attention and public health preparedness initiatives. Governing bodies such as the U.S. Food and Drug Administration feature the critical role of in-vitro diagnostics in clinical decision-making and maintain structured approval frameworks for such technologies, while post-pandemic focus on molecular diagnostics has further strengthened implementation. Similarly, in Europe and Switzerland, updated in-vitro diagnostic regulations were displayed to enhance patient safety, strengthen quality management systems, and encourage reliable diagnostic innovation.

Biochips Based In-Vitro Diagnostics Market- Market Dynamics

Digital transformation of laboratories and point-of-care testing expansion are supporting market growth

Healthcare systems are developing important aspects supporting the progress of biochips-based in-vitro diagnostics as they are making diagnostic procedures faster, more connected, and more accessible. Evolved laboratories are increasingly shifting from manual and time-consuming means to automated and digitally integrated systems, where biochip technologies can process multiple tests at once with higher efficiency. For example, India's Ayushman Bharat Digital Mission is following integration of digital health infrastructure, while China's National Medical Products Administration is encouraging regulatory association for digital diagnostic solutions.

Japan's Ministry of Health, Labour and Welfare is also progressing modernization of clinical testing atmospheres through structured digital health initiatives, enhancing efficiency and data connectivity in diagnostics. On the manufacturing side, Sysmex Corporation is advancing automated hematology and diagnostic systems that progress laboratory workflow efficiency, while Becton Dickinson is increasing point-of-care testing platforms that aid faster diagnostic decisions at patient locations.

Biochips Based In-Vitro Diagnostics Market- Segmentation Analysis:

The Global Biochips Based In-Vitro Diagnostics Market is segmented on the basis of Product Type, Application, End-User, Technology, and Region.

The market is divided into three categories based on product type: consumables, instruments and software. The consumables continue to be widely implemented as it depends on recurring use of reagents, cartridges, and test kits that sustenance continuous diagnostic workflows in laboratories and clinical settings. These items are important for each testing cycle, making them a constant requirement across healthcare facilities using molecular and chip-based structures. Companies such as QIAGEN have reinforced their consumable-based diagnostic contributions by growing cartridge-driven sample preparation and molecular testing solutions. In the same way, bioMerieux has enhanced production and deployment of single-use diagnostic reagent kits to support faster infectious disease testing and laboratory efficiency.

The market is differed into three classes as per end-user: research institutions, hospitals and clinics, and diagnostic centers. Hospitals and clinics are widely relied upon, because they serve as the primary point of patient care where rapid and accurate diagnostic decisions are essential. These facilities handle large volumes of patients with varied health circumstances, making them dependent on innovative diagnostic tools that can deliver quick results and support immediate treatment decisions. Firms like; Roche Diagnostics have expanded their hospital-focused molecular testing platforms to support integrated diagnostic workflows in clinical environments. Similarly, Siemens Healthineers has strengthened its hospital laboratory solutions by enhancing automated diagnostic systems designed for faster clinical decision-making and improved workflow efficiency.

Biochips Based In-Vitro Diagnostics Market- Geographical Insights

Regional analysis of the biochips based in-vitro diagnostics space highlights how healthcare innovation and diagnostic adoption differ based on scientific capability and regulatory support. Among global regions, North America demonstrates a notable contribution due to its strong research ecosystem, regulatory clarity, and high adoption of precision diagnostics. The U.S. National Institutes of Health has supported large-scale precision medicine and genomic research programs, including major initiatives involving molecular profiling for cancer and chronic disease studies. The U.S. Food and Drug Administration also provide structured approval pathways for advanced in-vitro diagnostic devices, supporting faster introduction of biochip-based technologies in clinical use.

Additionally, CMS reimbursement coverage for molecular diagnostic also procedures further encourage adoption in healthcare systems. From the business side, Thermo Fisher Scientific has lengthened biochip-enabled genomic and proteomic platforms used in research and clinical diagnostics, while Illumina continues to reinforce sequencing-based biochip solutions maintained by large-scale genomic initiatives and precision medicine plans.

UK Biochips Based In-Vitro Diagnostics Market- Country Insights

The United Kingdom demonstrates a stable and structured development, maintained by well-established public healthcare systems, research funding, and regulatory outlines that encourage early acceptance of advanced diagnostic technologies. The country places its focus on early disease detection, adapted treatment approaches, and the integration of advanced diagnostic skills into routine clinical practice. The National Health Service has expanded the use of genomic and molecular testing under its Genomic Medicine Service, supporting broader integration of precision diagnostics in routine care. The UK Department of Health and Social Care has also increased investment in life sciences innovation through its Life Sciences Vision policy, directing to accelerate development and use of progressive diagnostic tools with microarray and biochip-based systems.

Furthermore, the UK Health Security Agency continues to support national diagnostic awareness by improving laboratory surveillance and molecular testing abilities for infectious disease monitoring. From the industry side, Oxford Nanopore Technologies are progressing chip-based sequencing platforms that support rapid genomic study. These combined government initiatives and technological partnerships support a strong foundation for diagnostic innovation and clinical adoption in the country.

Biochips Based In-Vitro Diagnostics Market- Competitive Landscape:

The Biochips Based In-Vitro Diagnostics market is developing as a science-driven healthcare network where medical technology firms, biotechnology developers, and diagnostic solution providers work together to advance disease detection and patient care. Evolution in this field is reinforced by rising use of genetic testing, rapid screening tools, and lab-on-chip systems that help carry faster and more precise outcomes. Healthcare institutions, research laboratories, and diagnostic centers are steadily implementing these solutions to improve clinical decision-making and workflow efficiency. The space is also formed by continuous innovation in microarray systems, biosensors, and automated molecular platforms, supported by collaborations with research organizations and healthcare networks.

Key participants comprise Illumina, Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, and Danaher Corporation, all supporting to developments in biochip-enabled diagnostic solutions. For instance, Illumina strengthened its genomic testing ecosystem by improving chip-based sequencing workflows to support more accurate precision medicine applications. Likewise, Agilent Technologies enhanced its microarray platforms to recover sensitivity in biomarker detection, especially in oncology and disease research uses.

Recent Developments:

In June 2025, Bio-Rad Laboratories expanded its collaboration with research institutions to develop next-generation chip-based multiplex diagnostic assays, enabling simultaneous detection of multiple disease markers from a single sample. This collaboration strengthens multiplex diagnostics, improving efficiency, accuracy, and accelerating early disease detection across diverse clinical and research settings.

In March 2025, Roche Diagnostics expanded its molecular diagnostics portfolio by strengthening its collaboration with clinical laboratories to integrate next-generation biochip-enabled PCR systems for faster infectious disease detection. This development strengthens rapid diagnostics, improves laboratory efficiency, and supports advanced molecular testing through integrated biochip-based PCR systems.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Agilent Technologies
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Illumina
  • Bio-Rad Laboratories
  • PerkinElmer
  • QIAGEN
  • Danaher Corporation
  • GE HealthCare
  • Siemens Healthineers
  • bioMerieux
  • Becton Dickinson
  • Merck KGaA
  • Standard BioTools
  • DiaSorin
  • Tecan Group
  • Randox Laboratories
  • HORIBA
  • LI-COR Biosciences
  • Others

GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Consumables
  • Reagents & Kits
  • Biochips/Microarrays
  • Instruments
  • Chip Readers & Scanners
  • PCR Systems
  • Microfluidic Devices
  • Others
  • Software & Services
  • Others

GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Lab-On-Chip Applications
  • DNA Applications
  • Protein Microarrays
  • Others

GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033

  • Research Institutions
  • Hospitals and Clinics
  • Diagnostic Centers
  • Others

GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Microarray Technology
  • Biosensor Technology
  • PCR-Integrated Biochips
  • Nanotechnology-Based Chips
  • Microfluidics-Based Systems
  • Others

GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA
Product Code: ANV6547

Table of Contents

1. Biochips Based In-Vitro Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biochips Based In-Vitro Diagnostics Market Snippet by Product Type
    • 2.1.2. Biochips Based In-Vitro Diagnostics Market Snippet by Application
    • 2.1.3. Biochips Based In-Vitro Diagnostics Market Snippet by End-User
    • 2.1.4. Biochips Based In-Vitro Diagnostics Market Snippet by Technology
    • 2.1.5. Biochips Based In-Vitro Diagnostics Market Snippet by Country
    • 2.1.6. Biochips Based In-Vitro Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Biochips Based In-Vitro Diagnostics Key Market Trends

  • 3.1. Biochips Based In-Vitro Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biochips Based In-Vitro Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biochips Based In-Vitro Diagnostics Market Opportunities
  • 3.4. Biochips Based In-Vitro Diagnostics Market Future Trends

4. Biochips Based In-Vitro Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biochips Based In-Vitro Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Biochips Based In-Vitro Diagnostics Market Landscape

  • 6.1. Biochips Based In-Vitro Diagnostics Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biochips Based In-Vitro Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Consumables
      • 7.1.2.1. Reagents & Kits
      • 7.1.2.2. Biochips/Microarrays
    • 7.1.3. Instruments
      • 7.1.3.1. Chip Readers & Scanners
      • 7.1.3.2. PCR Systems
      • 7.1.3.3. Microfluidic Devices
      • 7.1.3.4. Others
    • 7.1.4. Software & Services
    • 7.1.5. Others

8. Biochips Based In-Vitro Diagnostics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Lab-On-Chip Applications
    • 8.1.3. DNA Applications
    • 8.1.4. Protein Microarrays
    • 8.1.5. Others

9. Biochips Based In-Vitro Diagnostics Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2025 & 2033 (%)
    • 9.1.2. Research Institutions
    • 9.1.3. Hospitals and Clinics
    • 9.1.4. Diagnostic Centers
    • 9.1.5. Others

10. Biochips Based In-Vitro Diagnostics Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 10.1.2. Microarray Technology
    • 10.1.3. Biosensor Technology
    • 10.1.4. PCR-Integrated Biochips
    • 10.1.5. Nanotechnology-Based Chips
    • 10.1.6. Microfluidics-Based Systems
    • 10.1.7. Others

11. Biochips Based In-Vitro Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Biochips Based In-Vitro Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Biochips Based In-Vitro Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Biochips Based In-Vitro Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Biochips Based In-Vitro Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Biochips Based In-Vitro Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Biochips Based In-Vitro Diagnostics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Agilent Technologies
    • 12.2.3. Thermo Fisher Scientific
    • 12.2.4. F. Hoffmann-La Roche
    • 12.2.5. Illumina
    • 12.2.6. Bio-Rad Laboratories
    • 12.2.7. PerkinElmer
    • 12.2.8. QIAGEN
    • 12.2.9. Danaher Corporation
    • 12.2.10. GE HealthCare
    • 12.2.11. Siemens Healthineers
    • 12.2.12. bioMerieux
    • 12.2.13. Becton Dickinson
    • 12.2.14. Merck KGaA
    • 12.2.15. Standard BioTools
    • 12.2.16. DiaSorin
    • 12.2.17. Tecan Group
    • 12.2.18. Randox Laboratories
    • 12.2.19. HORIBA
    • 12.2.20. LI-COR Biosciences
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!